C-Reactive Protein: A Prognostic Biomarker for ALS?
Serum levels of C-reactive protein (CRP) appear to be a "useful, feasible, and potentially prognostic factor" in patients with amyotrophic lateral sclerosis (ALS), a new study has suggested. The authors also note that high CRP levels may identify patients with ALS who respond better to a new drug in development for the condition. The findings were published online in JAMA Neurology on April 3, by a group led by Christian Lunetta, MD, NeuroMuscular Omnicentre, Fondazione Serena Onlus, Milan, Italy.
@aishee CRP correlated very well with the severity of ALS in two different data sets," coauthor Stanley H. Appel, MD, chair for the Treatment and Research of ALS, Neurological Institute, Houston Methodist Hospital, Texas, commented to Medscape Medical News. These showed that if patients are progressing faster, their CRP levels are higher. That is extremely interesting